Chasing the Yield
Investing for income through dividends and distributions
-
2021 Yields in Review
2021 comes to an end. Procter & Gamble issues recall, Exxon CFO takes on debt, Self Storage is booming, I review some of my best performers of the year, and much much more!
-
Self Storage is booming during the pandemic
Public Storage (PSA) has done well for me since August of 2020. It’s up 51.3% in my Medium Yield Portfolio. Their current dividend yield is 2.19%. Self-storage stocks have been big gainers since last year’s economic lockdown, outrunning e-commerce warehouses, rebounding malls and rental houses. Investors dumped self-storage stocks when the pandemic hit, unaware that the…
-
Exxon CFO to take on debt reduction and address spending
Exxon took on about $21 billion in new debt in 2020 in response to the sharp declines in its business caused by the pandemic. The company this year has paid down billions, which helped bring its net debt down to $51.83 billion as of Sept. 30, from $68.57 billion at the end of December, according…
-
Procter & Gamble issues recall for a variety of products after benzene detected in some
The affected products include dry shampoos and dry conditioners from Pantene, Aussie and Herbal Essences, produced in the U.S. The consumer-goods company said it started investigating its products after news reports of other aerosol products containing benzene. In July, Johnson & Johnson recalled most of its Neutrogena and Aveeno spray sunscreens after it found the chemical in some of its products.…
-
Coal in our stockings?
Market opens down over 1.5%, Senator Manchin tears down BBB, inflation in Reading PA., world on the verge of a Nutella shortage, and much much more!
-
CDC advisers recommend Pfizer or Moderna’s shots over Johnson & Johnson’s
The Advisory Committee on Immunization Practices voted 15 to 0 to make the recommendation Thursday after hearing updates from Centers for Disease Control and Prevention officials on reports of J&J vaccine recipients experiencing blood clots combined with low blood-platelet levels. The updated position is likely to deal another blow to the use of the J&J…